24 January 2023 - Potential first FDA approved therapy for treatment of molluscum contagiosum.
Verrica Pharmaceuticals today announced that it has resubmitted the new drug application for VP-102 for the treatment of molluscum contagiosum (molluscum) to the US FDA.